$0.47 EPS Expected for HCP, Inc. (HCP)

January 16, 2018 - By Richard Conner

 $0.47 EPS Expected for HCP, Inc. (HCP)
Investors sentiment decreased to 0.85 in Q3 2017. Its down 0.38, from 1.23 in 2017Q2. It worsened, as 54 investors sold HCP, Inc. shares while 188 reduced holdings. 43 funds opened positions while 163 raised stakes. 411.39 million shares or 0.00% less from 411.39 million shares in 2017Q2 were reported.
19,150 are held by Cypress Group. Putnam Invests Ltd reported 427,830 shares. Brinker Capital reported 12,438 shares stake. Stonebridge Capital Ltd Liability stated it has 40,710 shares. Fdx Inc stated it has 10,471 shares. Reilly Advsr Ltd Liability stated it has 0% of its portfolio in HCP, Inc. (NYSE:HCP). Fagan Assoc stated it has 0.47% in HCP, Inc. (NYSE:HCP). Dubuque Commercial Bank stated it has 15,326 shares or 0.07% of all its holdings. Echo Street Cap Mgmt Limited Com holds 218,304 shares. Teachers Retirement System Of The State Of Kentucky invested in 53,400 shares. Amica Pension Fund Board Of Trustees reported 0.06% stake. Macquarie Group Incorporated Limited has invested 0.04% in HCP, Inc. (NYSE:HCP). First Trust Advsr Lp owns 559,934 shares. Swiss Natl Bank reported 0.05% of its portfolio in HCP, Inc. (NYSE:HCP). Legal And General Grp Incorporated Public Ltd Company holds 3.58M shares or 0.07% of its portfolio.

Analysts expect HCP, Inc. (NYSE:HCP) to report $0.47 EPS on February, 12.They anticipate $0.12 EPS change or 20.34 % from last quarter’s $0.59 EPS. HCP’s profit would be $222.36M giving it 12.62 P/E if the $0.47 EPS is correct. After having $0.48 EPS previously, HCP, Inc.’s analysts see -2.08 % EPS growth. The stock increased 0.34% or $0.08 during the last trading session, reaching $23.72. About 3.89M shares traded or 4.23% up from the average. HCP, Inc. (NYSE:HCP) has risen 8.01% since January 17, 2017 and is uptrending. It has underperformed by 8.69% the S&P500.

HCP, Inc. (NYSE:HCP) Ratings Coverage

Among 20 analysts covering HCP (NYSE:HCP), 5 have Buy rating, 1 Sell and 14 Hold. Therefore 25% are positive. HCP had 70 analyst reports since September 8, 2015 according to SRatingsIntel. The rating was upgraded by Bank of America to “Neutral” on Tuesday, October 4. The firm has “Hold” rating by BMO Capital Markets given on Tuesday, August 1. The firm earned “Underweight” rating on Wednesday, June 22 by Morgan Stanley. The company was upgraded on Monday, March 20 by Morgan Stanley. As per Monday, July 3, the company rating was maintained by BMO Capital Markets. Mizuho upgraded the shares of HCP in report on Monday, November 21 to “Buy” rating. The company was maintained on Monday, October 16 by KeyBanc Capital Markets. The rating was downgraded by Barclays Capital to “Underweight” on Wednesday, January 6. Citigroup maintained it with “Neutral” rating and $38 target in Wednesday, August 24 report. The stock has “Buy” rating by Bank of America on Monday, April 3.

HCP, Inc. is a fully integrated real estate investment trust that invests primarily in real estate serving the healthcare industry in the United States. The company has market cap of $11.22 billion. HCP owns a large-scale portfolio diversified across multiple sectors, led by senior housing, life science and medical office. It has a 20.97 P/E ratio. Recognized as a global leader in sustainability, HCP has been a publicly-traded firm since 1985 and was the first healthcare REIT selected to the S&P 500 index.

More news for HCP, Inc. (NYSE:HCP) were recently published by: Seekingalpha.com, which released: “Lanny’s Recent Stock Purchase – HCP, Inc.” on December 25, 2017. Twst.com‘s article titled: “HCP Inc.: HCP to Report Fourth Quarter and Year-End 2017 Financial Results and …” and published on January 16, 2018 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.